The FDA has approved a new drug from Eli Lilly to help Americans lose weight: Zepbound. The drug is a new formula of the popular diabetes treatment Mounjaro and it joins other medications like Ozempic and Wegovy as weapons against obesity. Emergency medicine physician Dr. Owais Durrani joined CBS News to discuss the new drug and its potential side effects.
Source: CBS Minnesota
FDA approves weight loss drug Zepbound, joining Ozempic and Wegovy in market
Published in Fifty Lakes
More from Fifty LakesMore posts in Fifty Lakes »
- Zohran Mamdani won by shaking up NYC politics
- Cowboys' Marshawn Kneeland died from self-inflicted gunshot wound, DPS says
- Trump announces deal to lower weight loss drug prices for some Americans
- Senate talks continue over ending shutdown as Democrats weigh offer
- Can you negotiate a settlement on a payday loan? What borrowers should know
Be First to Comment